The N.C. Employment Security Commission is correcting a report in a monthly publication that stated Talecris Biotherapeutics was shutting down its corporate headquarters and its huge blood plasma therapy production plant in Clayton.
The layoffs were reported in the July issue of NC Today, which was published on Friday.
Talecris merged last month with Spain-based Grifols and now operates under that name.
A spokesperson for Grifols said the company was not making any layoffs.
The ESC, responding to calls from the media, investigated the report, which was listed in its “Announced Business Closings and Permanent Layoffs” for June.
“Unfortunately, the mistake was made on our end,” said Larry parker, the spokesperson for the ESC. He said a report appearing in March at WRAL Tech Wire was “misinterpreted.” A reference to “closing” was to the merger of the deal between Talecris and Grifols, not a closing of facilities.
The closings were removed from the online version, but a print version of the publication has already been issued, Parker said.
Grifols employs more than 400 people at its RTP headquarters and some 1,700 at the Clayton plant.
Get the latest news alerts: Follow WRAL Tech Wire at Twitter.
